A multicenter randomized controlled clinical trial of the superiority of compound polyethylene glycol 3350 (PEG) oral solution in the treatment of overt hepatic encephalopathy

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 9e02143d9589c5180c8fc01099521e9cf5c575fc
First added on: Apr 23, 2026